|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
|
US7883704B2
(en)
|
1999-03-25 |
2011-02-08 |
Abbott Gmbh & Co. Kg |
Methods for inhibiting the activity of the P40 subunit of human IL-12
|
|
JP2003530092A
(ja)
*
|
2000-03-17 |
2003-10-14 |
ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
ヒトＦＡＰ−α−特異抗体
|
|
PE20021080A1
(es)
*
|
2001-04-12 |
2003-02-12 |
Boehringer Ingelheim Int |
Un anticuerpo especifico fapo bibh1 en el tratamiento del cancer
|
|
US20060275287A1
(en)
*
|
2002-06-21 |
2006-12-07 |
Brad St Croix |
Scroll compressor
|
|
US8193318B2
(en)
|
2002-08-14 |
2012-06-05 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
|
JP4459810B2
(ja)
|
2002-08-14 |
2010-04-28 |
マクロジェニクス，インコーポレーテッド |
ＦｃγＲＩＩＢ特異的抗体とその利用法
|
|
US8946387B2
(en)
|
2002-08-14 |
2015-02-03 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
|
US8968730B2
(en)
|
2002-08-14 |
2015-03-03 |
Macrogenics Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
|
US8187593B2
(en)
|
2002-08-14 |
2012-05-29 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
|
US8530627B2
(en)
|
2002-08-14 |
2013-09-10 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
|
US8044180B2
(en)
|
2002-08-14 |
2011-10-25 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
|
US7384744B2
(en)
|
2002-11-29 |
2008-06-10 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products
|
|
US7960512B2
(en)
|
2003-01-09 |
2011-06-14 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
|
EP1587540B1
(en)
|
2003-01-09 |
2021-09-15 |
MacroGenics, Inc. |
IDENTIFICATION AND ENGINEERING OF ANTIBODIES WITH VARIANT Fc REGIONS AND METHODS OF USING SAME
|
|
EA200700469A1
(ru)
*
|
2003-02-14 |
2008-10-30 |
Байоджен Айдек Ма Инк. |
Экспрессионная кассета и вектор для временной или постоянной экспрессии экзогенных молекул
|
|
CA2565874C
(en)
|
2004-05-10 |
2017-10-03 |
Macrogenics, Inc. |
Humanized fc.gamma.riib-specific antibodies and methods of use thereof
|
|
AU2005335714B2
(en)
|
2004-11-10 |
2012-07-26 |
Macrogenics, Inc. |
Engineering Fc antibody regions to confer effector function
|
|
PL1919503T3
(pl)
|
2005-08-10 |
2015-04-30 |
Macrogenics Inc |
Identyfikacja i inżynieria przeciwciał ze zmiennymi regionami FC oraz sposoby ich stosowania
|
|
US10155816B2
(en)
*
|
2005-11-28 |
2018-12-18 |
Genmab A/S |
Recombinant monovalent antibodies and methods for production thereof
|
|
EP1806365A1
(en)
*
|
2006-01-05 |
2007-07-11 |
Boehringer Ingelheim International GmbH |
Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them
|
|
CA2660592C
(en)
|
2006-05-26 |
2016-07-12 |
Macrogenics, Inc. |
Humanized fc.gamma.riib-specific antibodies and methods of use thereof
|
|
EP2505209A1
(en)
|
2006-06-26 |
2012-10-03 |
MacroGenics, Inc. |
Fcgamma-RIIB-specific antibodies and methods of the use thereof
|
|
CA2656224C
(en)
|
2006-06-26 |
2018-01-09 |
Macrogenics, Inc. |
Combination of fc.gamma.riib antibodies and cd20-specific antibodies and methods of use thereof
|
|
US8652466B2
(en)
|
2006-12-08 |
2014-02-18 |
Macrogenics, Inc. |
Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting
|
|
US7776331B1
(en)
|
2007-01-16 |
2010-08-17 |
Abbott Laboratories |
Methods of treating plaque psoriasis
|
|
EP2527364A1
(en)
|
2007-03-29 |
2012-11-28 |
Abbott Laboratories |
Crystalline anti-human IL-12 antibodies
|
|
US9163249B2
(en)
*
|
2007-08-20 |
2015-10-20 |
Glaxo Group Limited |
Production methods
|
|
BRPI0820793A2
(pt)
*
|
2007-12-10 |
2015-06-16 |
Hoffmann La Roche |
Seprase como marcador de câncer
|
|
EP2071337A1
(en)
*
|
2007-12-10 |
2009-06-17 |
F.Hoffmann-La Roche Ag |
Seprase as a marker for cancer
|
|
WO2009074276A2
(en)
*
|
2007-12-10 |
2009-06-18 |
Roche Diagnostics Gmbh |
Marker panel for colorectal cancer
|
|
NZ602511A
(en)
|
2008-03-18 |
2014-03-28 |
Abbvie Inc |
Methods for treating psoriasis
|
|
SG189730A1
(en)
|
2008-04-02 |
2013-05-31 |
Macrogenics Inc |
Her2/neu-specific antibodies and methods of using same
|
|
JP5785490B2
(ja)
|
2008-04-02 |
2015-09-30 |
マクロジェニクス，インコーポレーテッド |
Ｂｃｒ複合体特異的抗体およびその使用方法
|
|
KR20120112384A
(ko)
|
2009-09-14 |
2012-10-11 |
애보트 게엠베하 운트 콤파니 카게 |
건선을 치료하는 방법
|
|
KR101808602B1
(ko)
|
2009-10-07 |
2017-12-13 |
마크로제닉스, 인크. |
푸코실화 정도의 변경으로 인해 개선된 이펙터 기능을 나타내는 Ｆｃ 영역-함유 폴리펩티드, 그것의 사용 방법
|
|
US9150656B2
(en)
|
2010-03-04 |
2015-10-06 |
Macrogenics, Inc. |
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof
|
|
PH12012501751A1
(en)
|
2010-03-04 |
2012-11-12 |
Macrogenics Inc |
Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
|
|
PL2603530T3
(pl)
|
2010-08-13 |
2018-03-30 |
Roche Glycart Ag |
Przeciwciała anty-FAP i sposoby stosowania
|
|
MX337040B
(es)
|
2010-09-09 |
2016-02-09 |
Pfizer |
Moleculas de union a 4-1bb.
|
|
LT3075745T
(lt)
|
2011-02-10 |
2018-11-26 |
Roche Glycart Ag |
Mutavę interleukino-2 polipeptidai
|
|
SG11201408161RA
(en)
|
2012-06-08 |
2015-01-29 |
Sutro Biopharma Inc |
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
|
EP3135690A1
(en)
|
2012-06-26 |
2017-03-01 |
Sutro Biopharma, Inc. |
Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
|
|
US9487587B2
(en)
|
2013-03-05 |
2016-11-08 |
Macrogenics, Inc. |
Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
|
|
UA118028C2
(uk)
|
2013-04-03 |
2018-11-12 |
Рош Глікарт Аг |
Біспецифічне антитіло, специфічне щодо fap і dr5, антитіло, специфічне щодо dr5, і спосіб їх застосування
|
|
CN103267852B
(zh)
*
|
2013-05-15 |
2015-03-25 |
中国医学科学院北京协和医院 |
成纤维激活蛋白α在制备胰腺癌预后试剂盒中的用途
|
|
ES2658039T3
(es)
|
2013-07-10 |
2018-03-08 |
Sutro Biopharma, Inc. |
Anticuerpos que comprenden múltiples residuos de aminoácidos no naturales sitio-específicos, métodos para su preparación y métodos de uso
|
|
GB201402006D0
(en)
|
2014-02-06 |
2014-03-26 |
Oncomatryx Biopharma S L |
Antibody-drug conjugates and immunotoxins
|
|
DK3122775T3
(da)
*
|
2014-03-26 |
2020-02-03 |
Univ Wuerzburg J Maximilians |
Monoklonale antistoffer til vækst- og differentieringsfaktor 15 (gdf-15), og anvendelser deraf til behandling af cancer kakeksi og cancer
|
|
CN105646710B
(zh)
*
|
2014-11-17 |
2020-08-25 |
四川科伦博泰生物医药股份有限公司 |
一种全人源化抗vegfr-2单克隆抗体及其制备方法
|
|
KR20180053674A
(ko)
|
2015-10-02 |
2018-05-23 |
에프. 호프만-라 로슈 아게 |
공자극 tnf 수용체에 특이적인 이중특이성 항체
|
|
US11708413B2
(en)
*
|
2016-01-27 |
2023-07-25 |
Sutro Biopharma, Inc. |
Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugates
|
|
MY198114A
(en)
|
2016-04-15 |
2023-08-04 |
Macrogenics Inc |
Novel b7-h3-binding molecules, antibody drug conjugates thereof and methods of use thereof
|
|
EP3478321A4
(en)
|
2016-06-30 |
2020-04-22 |
Oncorus, Inc. |
Pseudotyped oncolytic viral delivery of therapeutic polypeptides
|
|
JP2018035137A
(ja)
|
2016-07-13 |
2018-03-08 |
マブイミューン ダイアグノスティックス エイジーＭａｂｉｍｍｕｎｅ Ｄｉａｇｎｏｓｔｉｃｓ Ａｇ |
新規な抗線維芽細胞活性化タンパク質（ｆａｐ）結合薬剤およびその使用
|
|
WO2018111989A1
(en)
|
2016-12-14 |
2018-06-21 |
Purdue Research Foundation |
Fibroblast activation protein (fap)-targeted imaging and therapy
|
|
EP3731850A4
(en)
|
2017-12-29 |
2021-12-01 |
Oncorus, Inc. |
ONCOLYTIC VIRUS DELIVERY OF THERAPEUTIC POLYPEPTIDES
|
|
CN110526991A
(zh)
*
|
2018-05-25 |
2019-12-03 |
深圳宾德生物技术有限公司 |
靶向fap的嵌合抗原受体、嵌合抗原受体t细胞及其制备方法和应用
|
|
CN110526979A
(zh)
*
|
2018-05-25 |
2019-12-03 |
深圳宾德生物技术有限公司 |
靶向fap的单链抗体、嵌合抗原受体t细胞及其制备方法和应用
|
|
CN109053893B
(zh)
*
|
2018-08-15 |
2021-03-30 |
智享生物(苏州)有限公司 |
一种抗d-二聚体单克隆抗体及其制备方法
|
|
CN112972675A
(zh)
*
|
2018-09-07 |
2021-06-18 |
上海君实生物医药科技股份有限公司 |
抗pd-1抗体在治疗肿瘤中的用途
|
|
CN114853908B
(zh)
*
|
2019-05-16 |
2024-06-07 |
浙江道尔生物科技有限公司 |
一种治疗代谢疾病的融合蛋白
|
|
EP3763726A1
(en)
|
2019-07-08 |
2021-01-13 |
3B Pharmaceuticals GmbH |
Compounds comprising a fibroblast activation protein ligand and use thereof
|
|
HUE070009T2
(hu)
|
2019-07-08 |
2025-05-28 |
3B Pharmaceuticals Gmbh |
Fibroblaszt aktiváló protein ligandumot tartalmazó vegyületek és alkalmazásuk
|
|
BR112022000144A2
(pt)
|
2019-07-08 |
2022-02-22 |
3B Pharmaceuticals Gmbh |
Compostos que compreendem um ligante de proteína de ativação de fibroblastos e uso dos mesmos
|
|
CN114206929B
(zh)
*
|
2019-09-03 |
2023-12-22 |
百奥泰生物制药股份有限公司 |
一种抗tigit免疫抑制剂及应用
|
|
CN113512116B
(zh)
*
|
2020-04-10 |
2022-09-20 |
苏州普乐康医药科技有限公司 |
一种抗igf-1r抗体及其应用
|
|
KR102363980B1
(ko)
*
|
2020-04-13 |
2022-02-15 |
전남대학교산학협력단 |
전이성 뇌종양의 진단 또는 예후 분석용 바이오마커 및 이를 이용한 진단방법
|
|
JP2023523977A
(ja)
*
|
2020-04-30 |
2023-06-08 |
アイ－マブ バイオファーマ ユーエス リミテッド |
抗ｃｄ４７抗体を含む医薬組成物
|
|
WO2021236658A1
(en)
|
2020-05-19 |
2021-11-25 |
Boehringer Ingelheim International Gmbh |
Binding molecules for the treatment of cancer
|
|
WO2022007283A1
(zh)
*
|
2020-07-08 |
2022-01-13 |
深圳霁因生物医药转化研究院 |
用于诊断fap表达异常相关疾病的试剂盒、方法及计算机可读存储介质
|
|
US20230295258A1
(en)
*
|
2020-08-11 |
2023-09-21 |
Kanaph Therapeutics Inc. |
Fusion protein comprising il-12 and anti-fap antibody, and use thereof
|
|
EP4050018A1
(en)
|
2021-01-07 |
2022-08-31 |
3B Pharmaceuticals GmbH |
Compounds comprising a fibroblast activation protein ligand and use thereof
|
|
WO2022148843A1
(en)
|
2021-01-07 |
2022-07-14 |
3B Pharmaceuticals Gmbh |
Compounds comprising a fibroblast activation protein ligand and use thereof
|
|
WO2023031644A1
(en)
|
2021-08-31 |
2023-03-09 |
Full-Life Technologies Limited |
Anti-fibroblast activation protein (fap) single domain antibodies and uses thereof
|
|
EP4457346A1
(en)
*
|
2021-12-30 |
2024-11-06 |
Concept to Medicine Biotech Co., Ltd. |
Human antibodies against fap-alpha
|
|
CN119604540A
(zh)
|
2022-08-03 |
2025-03-11 |
南京维立志博生物科技股份有限公司 |
靶向FAP和TGFβ的抗体融合蛋白及其用途
|
|
CN120112308A
(zh)
|
2022-10-07 |
2025-06-06 |
吉尼松公司 |
使用抗fap car-t细胞免疫治疗骨骼肌病
|
|
CN116589566A
(zh)
*
|
2022-11-18 |
2023-08-15 |
昆明医科大学第一附属医院 |
一种HIV-1中和抗体的改造重组单克隆IgM抗体及其应用
|
|
WO2025152756A1
(zh)
*
|
2024-01-15 |
2025-07-24 |
迈威(上海)生物科技股份有限公司 |
重组抗fap抗体及其应用
|
|
CN118496382B
(zh)
*
|
2024-05-22 |
2025-01-07 |
山东第一医科大学附属省立医院(山东省立医院) |
一种靶向fap的嵌合抗原受体、car-t细胞及其在肝纤维化中的应用
|
|
CN119265201A
(zh)
*
|
2024-08-23 |
2025-01-07 |
中国人民解放军海军军医大学第一附属医院 |
编码基因、蛋白、表达il-15的nkg2dl-fap双靶点car-nk细胞及其构建方法和用途
|